Pipeline
Generoath is moving into the future today.
Pipeline
Generoath is working to address a range of neurodegenerative diseases. Each of our investigational programs currently uses as adeno-associated viral (AAV) vector developed and manufactured by the team Generoath
in vitro
in vivo poc
Toxicity study
IND filling
Clinical trials
GO-101
(Parkinson’ s Disease)
(Parkinson’ s Disease)
GO-102
(ALS)
(ALS)
GO-201
(Retinal Neuro Degenerative Disease)
(Retinal Neuro Degenerative Disease)
GO-301
(Musculoskeletal Inflammatory Disease)
(Musculoskeletal Inflammatory Disease)
GO-401
(Stem Cell Engraftment)
(Stem Cell Engraftment)